Viridian Capital Leads Financing for Israel's Leading Cannabis Biotech Company

Breath of Life Pharma (“BOL Pharma” or the “Company”), an Israel-based cannabis biotech company conducting numerous clinical trials in Israel, has closed an $11.1-million growth capital round that was oversubscribed. Viridian Capital Advisors ("VCA"), through its broker dealer Pickwick Capital Partners, LLC (Member of FINRA/SIPC) served as the placement agent for the Company.

---